Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-25 @ 2:46 AM
NCT ID:
NCT00594633
Eligibility Criteria:
Inclusion Criteria:
* diagnosed with a brain tumor and treated with cranial irradiation and/or chemotherapy, and in stable remission of their disease at the time of enrollment.
* completed radiation and/or chemotherapy treatment at least 6 months prior to being enrolled in the study.
* who obtain a Mini-Mental Status Examination (MMSE) score ranging from 18 to 28 at the time of enrollment.
* are at least 18 years of age.
* are English speaking.
* have capacity to give consent
Exclusion Criteria:
* Patients with active or progressive disease on recent MRI of the brain either at the time of enrollment, or during the study period.
* with a pre-existing uncontrolled seizure disorder, or significant renal or hepatic impairment.
* taking the following medications: antipsychotics, psychostimulants.
* patients who have been on selective serotonin re-uptake inhibitors (SSRIs) for less than 3 months at the time of enrollment.
* with uncontrolled behavioral or mood disturbances.
* have their anticonvulsant medication(s) or dosage(s) changed less than 30 days prior to enrollment.
* currently receiving donepezil or other cholinesterase inhibitors.
* who is pregnant.
* unable to cooperate or complete cognitive tests.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00594633
Study Brief:
Protocol Section:
NCT00594633